Bristol-Myers: A Potential Turnaround Investment

This chapter explores investment opportunities in Bristol-Myers, focusing on its strategic transformation under new leadership and promising drug developments like Cobenfee for schizophrenia. The analysis considers recent market trends and challenges, projecting confidence in the company's future amidst a dynamic pharmaceutical landscape.